Patent details

EP2012809 Title: USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT

Basic Information

Publication number:
EP2012809
PCT Application Number:
PCT/US/2007/006042
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077527240
PCT Publication Number:
WO/2007/106385
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT
French Title of Invention:
UTILISATION D'UN AGONISTE DE LA GHRÉLINE POUR AMÉLIORER LES EFFETS CATABOLIQUES D'UN TRAITEMENT AUX GLUCOCORTICOÏDES
German Title of Invention:
VERWENDUNG EINES GHRELIN-AGONISTEN ZUR ERHÖHUNG DER KATABOLISCHEN WIRKUNG EINER GLUKOKORTIKOIDBEHANDLUNG
SPC Number:

Dates

Filing date:
09/03/2007
Grant date:
22/05/2013
EP Publication Date:
22/05/2013
PCT Publication Date:
20/09/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/01/2009
EP B1 Publication Date:
22/05/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/03/2014
Expiration date:
09/03/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/03/2007
 
 

Name:
IPSEN PHARMA
Address:
65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France (FR)

Inventor

1

Name:
CULLER Michael, Dewitt
Address:
United States (US)

2

Name:
GIUSTINA Andrea
Address:
Italy (IT)

3

Name:
TULIPANO Giovanni
Address:
Italy (IT)

4

Name:
DONG Zheng, Xin
Address:
United States (US)

Priority

Priority Number:
781172 P
Priority Date:
10/03/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/25;
Filing date Document type Number of pages